HC Wainwright restated their buy rating on shares of Mineralys Therapeutics (NASDAQ:MLYS – Free Report) in a report issued on Monday morning,Benzinga reports. The firm currently has a $30.00 price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback